原位雜合反應(ISH) 市場規模、佔有率和成長分析（按產品、技術、應用、最終用戶和地區）：產業預測 (2025-2032)

2023年全球原位雜合反應（ISH）市場規模預計為21億美元，從2024年的23.6億美元成長到2032年的60.6億美元，預測期間（2025年-2032年）預計複合年成長率為12.5 % 。

原位雜合反應(ISH) 市場由於其在分子診斷、基因編輯和重組 DNA 技術中的關鍵作用而正在經歷顯著成長。該技術可以對細胞和組織內的核酸進行定位和定量，並提供高靈敏度和準確性。已應用於分子生物學、免疫學、發育生物學、血液病理學等多個領域，特別提高了在疾病預後、藥物發現、生物標記開發等領域的研究能力。近年來，大量的研究和開發工作致力於高性能、經濟高效和快速多重技術的創新，例如 PLISH（鄰近連接原位雜合技術）。這些進步有助於更深入了解細胞功能，進一步促進市場擴張。

目錄

介紹

• 分析目的
• 市場範圍
• 定義

分析方法

• 資訊採購
• 次要/主要資料方法
• 市場規模預測
• 市場假設與約束

執行摘要

• 市場概況及展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及前景

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 抑制因素和挑戰
• 波特分析

主要市場考慮因素

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場魅力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 價格分析
• 技術分析
• 監管分析
• 專利分析
• 案例研究

全球原位雜合反應(ISH) 市場規模與複合年成長率：按產品分類（2025-2032 年）

• 市場概況
• 消耗品
  • 探測
  • 試劑套件/試劑
  • 配件
• 裝置
• 軟體

全球原位雜合反應(ISH) 市場規模與複合年成長率：按技術分類（2025-2032 年）

• 市場概況
• 螢光原位雜合反應
  • DNA螢光原位雜合反應
  • RNA螢光原位雜合反應
  • PNA螢光原位雜合反應
• 顯色原位雜合反應

全球原位雜合反應（ISH）市場規模與複合年成長率：按應用分類（2025-2032）

• 市場概況
• 癌症診斷
• 細胞學
• 感染疾病診斷
• 神經科學
• 免疫學

全球原位雜合反應(ISH) 市場規模與複合年成長率：按最終用戶分類（2025-2032 年）

• 市場概況
• 醫院/診斷實驗室
• 學術研究所

全球原位雜合反應（ISH）市場規模與複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東/非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲

競爭格局

• 前5名企業對比
• 主要企業市場定位（2024年）
• 主要企業採取的策略
• 近期市場趨勢
• 主要企業市場佔有率（2024年）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分類的佔有率分析
  • 收益與前一年同期比較（2022-2024）

主要企業簡介

• 雅培（美國）
• F. Hoffmann-La Roche AG（瑞士）
• 賽默飛世爾科技公司（美國）
• 丹納赫（美國）
• 安捷倫科技公司（美國）
• Biocare Medical, LLC（美國）
• Bio-Techne 公司（美國）
• QIAGEN NV（荷蘭）
• 默克公司（德國）
• 珀金埃爾默（美國）
• 恩佐生物化學（美國）
• Bio-Rad 實驗室（美國）
• 上元科技股份有限公司 (台灣地區)
• BioGenex 實驗室（美國）
• OpGen（美國）
• 生物 SB（美國）
• Abcam (UK)
• Zytomed 系統有限公司（德國）
• NeoGenomics 實驗室（美國）
• BioView（以色列）

結論和建議

Global In Situ Hybridization ISH Market size was valued at USD 2.1 billion in 2023 and is poised to grow from USD 2.36 billion in 2024 to USD 6.06 billion by 2032, growing at a CAGR of 12.5% during the forecast period (2025-2032).

The market for in-situ hybridization (ISH) is experiencing significant growth due to its pivotal role in molecular diagnostics, gene editing, and recombinant DNA technology. This technique allows for the localization and quantification of nucleic acids within cells and tissues, offering high sensitivity and accuracy. Its application across diverse fields, including molecular biology, immunology, developmental biology, and hematopathology, has enhanced research capabilities, particularly in disease prognosis, drug discovery, and biomarker development. Over the past few years, substantial R&D efforts have been made to innovate technologies like Proximity Ligation in situ Hybridization, which boasts high performance, cost-effectiveness, and rapid multiplexing. Such advancements are fostering a deeper understanding of cellular functions, further driving market expansion.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global In Situ Hybridization ISH Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global In Situ Hybridization ISH Market Segmental Analysis

Global In Situ Hybridization ISH Market is segmented by Product, Technology, Application, End-User and region. Based on Product, the market is segmented into Consumables, Instruments andSoftware. Based on Technology, the market is segmented into Fluorescent In Situ Hybridization and Chromogenic in Situ Hybridization. Based on Application, the market is segmented into Cancer Diagnostics, Cytology, Infectious Disease Diagnostics, Neuroscience and Immunology. Based on End-User, the market is segmented into Hospitals and Diagnostic Laboratories and Academic & Research Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global In Situ Hybridization ISH Market

The Global In Situ Hybridization (ISH) market is primarily driven by the alarming rise in cancer cases worldwide over recent years. Extensive research has unveiled recurrent genomic abnormalities as key contributors to various cancers. By integrating cytogenetic assays like ISH with DNA fluorescence in situ hybridization (FISH) and immunohistochemistry (IHC), researchers are now armed with advanced diagnostic tools that enhance their capabilities in cancer studies. Direct imaging of gene expression at the RNA level sheds light on the dynamics between cancer cells and their microenvironment, facilitating the evolution of diagnostic approaches. According to GLOBOCAN, the projected surge in cancer cases-estimated to reach 29.5 million globally by 2040-alongside the sharp increase in hemophilia incidences, underscores the pressing need for innovative diagnostic solutions. The escalating demand for ISH techniques in laboratories for chromosomal abnormalities and infectious disease diagnosis further propels market growth, alongside rising health expenditures and the prevalence of chronic illnesses like cancer and Alzheimer's disease.

Restraints in the Global In Situ Hybridization ISH Market

The Global In Situ Hybridization (ISH) market faces significant restraints that may hinder revenue growth. Short-lived fluorophore molecules present challenges, as the fluorescence signal diminishes rapidly over time, making fluorescence in situ hybridization (FISH) a time-sensitive technique. Additionally, FISH struggles with the detection of unbalanced translocations and low clonal cell populations in cases of minimal residual disease after cancer treatment. Further limitations include its reduced sensitivity compared to immunohistochemistry, relatively fewer false-positive results, and the risk of sample contamination during PCR processes. As a result, ISH is becoming less favored for diagnosing diseases with low pathogen loads due to its high detection threshold.

Market Trends of the Global In Situ Hybridization ISH Market

The Global In Situ Hybridization (ISH) market is witnessing a dynamic upward trend driven by advancements aimed at enhancing sensitivity and specificity in hybridization techniques. Innovations such as strand displacement amplification and molecular beacons are broadening the applications of ISH across research and diagnostic settings. These technologies enable the precise detection of low copy number nucleic acids, making them invaluable in fields like oncology, genetics, and infectious disease testing. As the demand for accurate and early diagnostics rises, coupled with increasing investments in research initiatives, the ISH market is poised for significant growth, reflecting its critical role in molecular biology and pathology.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Analysis
• Regulatory Analysis
• Patent Analysis
• Case Studies

Global In Situ Hybridization ISH Market Size by Product & CAGR (2025-2032)

• Market Overview
• Consumables
  • Probes
  • Kits & Reagents
  • Accessories
• Instruments
• Software

Global In Situ Hybridization ISH Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Fluorescent In Situ Hybridization
  • DNA Fluorescent in Situ Hybridization
  • RNA Fluorescent in Situ Hybridization
  • PNA Fluorescent in Situ Hybridization
• Chromogenic in Situ Hybridization

Global In Situ Hybridization ISH Market Size by Application & CAGR (2025-2032)

• Market Overview
• Cancer Diagnostics
• Cytology
• Infectious Disease Diagnostics
• Neuroscience
• Immunology

Global In Situ Hybridization ISH Market Size by End-User & CAGR (2025-2032)

• Market Overview
• Hospitals and Diagnostic Laboratories
• Academic & Research Institutes

Global In Situ Hybridization ISH Market Size & CAGR (2025-2032)

• North America (Product, Technology, Application, End-User)
  • US
  • Canada
• Europe (Product, Technology, Application, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Technology, Application, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Technology, Application, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Technology, Application, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Abbott (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biocare Medical, LLC (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Techne Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Enzo Biochem (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abnova Corporation (Taiwan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioGenex Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OpGen (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio SB (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abcam (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zytomed Systems GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NeoGenomics Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioView (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations